RebelBio Cohort V at Imperial White City Incubator
Home » Entrepreneurship » Accelerators and incubators » RebelBio launches a new biotech cohort in London

RebelBio launches a new biotech cohort in London

London, 16. January 2018 – RebelBio, a life sciences accelerator of SOSV, the accelerator VC, launches its latest cohort in London.

We’re in the middle of the genomic revolution and the RebelBio accelerator has just launched a new cohort in London to accelerate some of the most astonishing developments in the life sciences.

Increasing overlap with other technologies like machine learning, automation, faster DNA sequencing and synthesis are a few factors lowering the financial hurdles to entrepreneurship in the sector. In combination with capital, this enables entrepreneurs to de-risk their ventures earlier, pursue world-changing technologies and bring exciting consumer products to market.

Synthetic biology company Bolt Threads is raising $106 million. Meanwhile, early-stage companies, too, are advancing in the funding cycle: IndieBio startup Memphis Meats has secured $17 million from investors that include Bill Gates. Our graduate cell-free tech has captured public imagination with their bio-pixel computer and several of our portfolio companies, like Microsynbiotix, have recently raised investment, too.

Hence, to tap into this potential and support more entrepreneurs, RebelBio has expanded this year, running one program in Cork, Ireland and another one in London, UK.

The team has selected a new batch of ten top early-stage companies to join the accelerator for 12 weeks. Each startup has won an investment of up to $250’000. The program takes place at the world-renowned Imperial White City Incubator. It consists of mentoring and workshop sessions, talks, pitch training and 1:1 sessions on business and scientific development with access to labspace and an advanced hackspace. It will culminate in a DemoDay in London at the end of March, where the entrepreneurs pitch to investors.

The interdisciplinary companies are developing ground-breaking innovations in areas ranging from 3D cell cultures and stem cell manufacturing, AI-powered neural tech, de-centralized diagnostics and genomics to eco-fashion made from novel biomaterials and in human augmentation.

The 10 startups are:

AlgiKnit – Transforming the apparel ecosystem with rapidly re-newable bio-based textiles.

VivoKey Technologies – Your unforgettable digital identity solution

Encelo Laboratories – Universal access to stem cells

Chronomics – Epigenetic testing A.I platform to drive the future of personalised wellness

Visusnano – A novel medical device that will revolutionise cata-ract surgery

June (previously Corticare) – Personalised molecular health tracking anywhere and anytime

Magellan Life Sciences – Exploring new frontiers in sweet taste – the next generation non-caloric protein sweetener

Biomimetic Solutions – Developing innovative nanomaterials for re-generative medicine and 3D cell culture applications

Daekitech – Non invasive devices to diagnose and monitor chron-ic diseases, such as diabetes, with a disposable test strip that only uses saliva

Neurocreate – Neurofeedback and artificial intelligence, to aug-ment human cognition and achieve ‘Flow’ neurological states for peak performance and stress alleviation.

 

0
Elsa Sotiriadis

Elsa Sotiriadis

Elsa Sotiriadis, aka the Biofuturist, is a synthetic biologist, futurist, and director of a VC deep science accelerator. She also writes science fiction and has published critically-acclaimed poetry. Her mind-bending new sci-fi thriller The Antimatter Of Death, about a deadly cellular algorithm, is now available for pre-order.

Click here to join our weekly newsletter. We want to hear what you think about this article. Got a tip for our news team? Write to editorial@synbiobeta.com.